Miniscopes are a novel tool to explore migraines. Researchers @JonaINSCOPIX, Jonathan Nassi, and @PaoloBotta81, and collaborators at @LundbeckUS dive into how one-photon miniscopes uncover novel #therapeutic strategies for #migraine management. #neuro ▶️ https://t.co/CFTDHCyioI

Inscopix Discovery Lab at #SfN24 with 4 posters! 📍Migraine Therapeutics | Oct 6 | 8-12PM | PSTR067.10/C108 📍Antidepressant Profiling | Oct 7 | 8-12PM | PSTR182.07/M31 📍Antipsychotics | Oct 8 | 1-5PM | PSTR375.07/Z23 📍Therapeutic Assessment | Oct 9 | 8-12PM | PSTR407.17/I8

#SfN24 is coming up! Visit @Bruker booth #424 to meet the #Inscopix Discovery Lab team & learn how they’re using #miniscopes for preclinical neuroscience drug development. Grab the science program for presentations throughout the week! Secure a 1:1 here ➡️ https://t.co/fzOvReBCgI

Buongiorno #ECNP2024! 🌞 Day 1 has arrived, and we're excited to kick things off! @JonaINSCOPIX is there & presenting #Inscopix circuit-based neurobehavioral assay for profiling preclinical antidepressants (#P1600) and antipsychotics (#P3601)! 🔬 Don’t miss out

📣New webinar coming soon! @Inscopix‘s Translational Science Lead @JonaINSCOPIX & @PaoloBotta81 from #Lundbeck will discuss the Inscopix Discovery Lab's CRO services and new advances in #migraine drug discovery using @Inscopix #miniscopes. Register here ➡️ https://t.co/hDEQMDAwtf

Excited to present our collaboration with Supernus & Navitor at #SOBP2024! Our research using Inscopix #miniscope reveals unique prefrontal cortical activity effects of NV-5138, a Phase-2 antidepressant candidate, compared to ketamine & rapastinel. Don't miss our poster session⬇️

Exciting news #ADPD2024! In collaboration with Motac Neuroscience we used #miniscope-based imaging for preclinical assessments of target engagement in CNS disorders! 🧠 Join us for insights and discussion on accelerating therapeutic development for CNS disorders. 👉 Board # 0415

Are you joining @CosyneMeeting this year? @Inscopix Senior Staff Engineer, Alina Quereilhac, and our Lead Translational Scientist @JonaINSCOPIX will be in beautiful Lisbon for #COSYNE2024! Don't miss our poster presentation on the first day. We can't wait to see you there!

Discover the future of migraine treatment at #EHC2023! 🔬e-Poster P.202 presents our collaboration with @Lundbeck, utilizing miniscope-based blood vessel imaging to assess migraine therapeutic efficacy — a pivotal step in addressing a major cause of disability!

#ACNP2023 Don't miss @Inscopix lead scientist, @OliverHMiller, as he presents a groundbreaking approach to antidepressant profiling. Explore novel methods in assessing neurobehavioral impacts of antidepressants. See you today at the poster T155.

Migraine is a major cause of disability, highlighting the need for improved treatments. Collaborating with @Lundbeck, we utilize nVue in-vivo vessel imaging as an assay of migraine therapeutic efficacy. Visit the poster and our booth# 2823 at SfN 2023.  ⬇️ https://t.co/KGiAMEcX6Z

📢 A Must-Read Blog! by @JonaINSCOPIX exploring groundbreaking #psychosis research by @Seongsik_Yun & @jones_g_parker lab @Neuroscience_NU using #Inscopix nVista. Elevate your insights on antipsychotics 💊 & dopamine dynamics w/ these unique findings! 🧠 👉 https://t.co/bL00mIjhtc

📢Shout out to @Seongsik_Yun & the brilliant team @jones_g_parker lab! Their groundbreaking research, utilizing the #nVista #miniscope, unveils the crucial role of D1-SPN modulation in antipsychotic drug actions. Published in @NatureNeuro.👏👏 Read here:

The position is now LIVE! @Inscopix is seeking a (pre-doctoral) Research Associate! https://t.co/u8SooDeZQw We use miniscope imaging and behavior to study neuropsychiatric and neurodegenerative disorders, with an aim to gain biological insight and develop therapeutics.

“...preclinical insights from studying neural circuits are highly informative for understanding the human brain.”- Our CSO, Dr. David Gray, in his interview with @DDWJournal on the future of #neurotherapeutic discovery. Read the full article ⬇️

Say 👋 to our Field Scientific Consultant in Japan- @MarikoNishibe! Mariko has great depth of knowledge + expertise in #miniscope technology & circuit neuroscience, and we're excited to empower more groundbreaking research in the Japanese Inscopix community with her help. 🧠✨

What a wonderful day with the @Inscopix European community at our pre-FENS User Group Meeting! Thank you to everyone that participated, we hope you found the talks, group discussions (and long overdue in-person meeting!) helpful and fun. 🙂 See you tomorrow at #FENS2022! 🥳

#PressRelease 🗞 announcing the launch of the Inscopix Data Exploration, Analysis and Sharing (IDEAS) Platform with added features & tools, including a Peri-Event Analysis Workflow for turnkey secondary analysis of neural circuit activity. https://t.co/uiyQ6Wq0OJ #dataanalysis

Our Co-founder and CEO @KunalKGhosh and Field Scientist @JonaINSCOPIX spent the day at @Neuro_Bordeaux, a vibrant Inscopix hub of @univbordeaux researchers at the cutting-edge of brain science. 🧠✨ Thank you for hosting, @BaufretonJerome, @CyrilHerrylab, Daniela Cota & others!

ICYMI- This special @ISC_MJ #seminar is happening tomorrow! Drs. Nicolas Bonneau and @KarineLangou from the @Inscopix team have a fun agenda planned about all things Inscopix. 🧠 Register + RT to share! ⬇️ https://t.co/BuLsLCluDy #neurotwitter